
Celularity Inc
CELUNasdaqCIK 1752828HealthcareFiscal year ends Dec 31
Reports and events: 186 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-08-1921:32 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001213900-21-043760 |
| 2021-08-1617:23 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001213900-21-043155 |
| 2021-08-1617:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-21-043146 |
| 2021-08-0617:29 ET | S-1 | Registration statement | 0001213900-21-040814 |
| 2021-07-2617:16 ET | SC 13D | Ownership report, active investor | 0001213900-21-038710 |
| 2021-07-2616:12 ET | SC 13D | Ownership report, active investor | 0001140361-21-025617 |
| 2021-07-2216:13 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-038102 |
| 2021-07-1520:48 ET | 8-K | 5.07 Shareholder vote results | 0001213900-21-036933 |
| 2021-07-0117:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-035328 |
| 2021-06-2916:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-034718 |
| 2021-05-2417:22 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001213900-21-028857 |
| 2021-05-2417:16 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001213900-21-028849 |
| 2021-05-1417:09 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-026517 |
| 2021-05-1007:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-025266 |
| 2021-05-0516:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-024707 |
| 2021-04-3010:45 ET | 8-K | 4.02 Non-reliance on financial statements | 0001213900-21-023729 |
| 2021-04-1606:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-021819 |
| 2021-04-1416:42 ET | DEF 14A | Proxy statementPeriod 2021-05-14 | 0001213900-21-021542 |
| 2021-03-1808:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-016260 |
| 2021-03-0417:55 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001213900-21-013228 |
| 2021-01-0807:03 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-001040 |
| 2021-01-0414:10 ET | 8-K | 5.07 Shareholder vote results | 0001213900-21-000100 |
| 2020-12-0417:23 ET | DEF 14A | Proxy statementPeriod 2020-12-29 | 0001213900-20-041141 |
| 2020-12-0216:51 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001213900-20-040523 |
| 2020-11-1610:21 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001213900-20-037167 |
| 2020-08-1321:13 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001213900-20-021702 |
| 2020-05-1519:45 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001213900-20-012368 |
| 2020-03-2419:48 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001213900-20-007185 |
| 2019-11-1316:24 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001213900-19-023191 |
| 2019-08-0716:32 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001213900-19-014808 |
| 2019-07-1216:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-19-012593 |
| 2019-05-3016:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-19-009814 |
| 2019-05-2417:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-19-009582 |
| 2019-05-2417:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-19-009581 |
| 2019-05-1316:55 ET | S-1/A | Registration statement, amended | 0001213900-19-008444 |
| 2019-04-2616:23 ET | S-1 | Registration statement | 0001213900-19-007206 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 02:51 ET. Listed shows no prices and gives no investment advice.